Drug: GLEEVEC Injury: Malignant neoplasm progression Quarter: 2016Q3
Total Records: 9 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
85151576 | GLEEVEC | Malignant neoplasm progression | NOVARTIS | 58.05 YR | F | 63 KG | 20160721 | US |
123539712 | GLEEVEC | Malignant neoplasm progression | NOVARTIS | 0.00 | F | 58 KG | 20160721 | US |
124592334 | GLEEVEC | Malignant neoplasm progression | NOVARTIS | 18.00 YR | M | 0 | 20160707 | US |
125053773 | GLEEVEC | Malignant neoplasm progression | NOVARTIS | 82.11 YR | F | 55 KG | 20160825 | US |
125784671 | GLEEVEC | Malignant neoplasm progression | NOVARTIS | 0.00 | F | 0 | 20160721 | COUNTRY NOT SPECIFIED |
125856731 | GLEEVEC | Malignant neoplasm progression | NOVARTIS | 0.00 | F | 0 | 20160725 | US |
126015461 | GLEEVEC | Malignant neoplasm progression | JAZZ | 0.00 | 0 | 20160728 | CA | |
1016764614 | GLEEVEC | Malignant neoplasm progression | NOVARTIS | 0.00 | M | 0 | 20160822 | COUNTRY NOT SPECIFIED |
1035514710 | GLEEVEC | Malignant neoplasm progression | NOVARTIS | 0.00 | M | 0 | 20160923 | CA |
Total Records: 9 Number of Pages: 1